
Longevity Research
FOX04-DRI
$85.00
FOXO4-DRI, a D-retro-inverso peptide studied for disrupting FOXO4–p53 binding in cellular senescence research.
- Purity
- >99%
- Testing
- 3rd-party
- Shipping
- Tracked, discreet
$85.00In stock
1
For laboratory research use only. Not for human consumption. Full disclaimer
Need the Certificate of Analysis for this batch? Request a COA.
About FOX04-DRI
FOXO4-DRI (FOXO4-p53 Disrupting Peptide)
Senolytic precision research. Targeting the cellular aging pathway.
FOXO4-DRI is a retro-inverso peptide designed to disrupt the interaction between the FOXO4 transcription factor and p53 protein — a key survival mechanism in senescent cells. By interfering with this interaction, FOXO4-DRI has been studied for its potential to selectively induce apoptosis in senescent cells while leaving healthy cells unaffected. It represents one of the most targeted senolytic research compounds currently under investigation.
Research applications
- FOXO4-p53 protein interaction disruption and senolytic mechanism research
- Selective senescent cell apoptosis pathway investigation
- Cellular senescence clearance and tissue rejuvenation research
- p53 pathway modulation in aging cell populations
- Healthspan and longevity mechanism research at the cellular level



